Moody's (MCO) Competitors

CME Group (NASDAQ:CME) and Moody's (NYSE:MCO) are both large-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.

Which has more risk & volatility, CME or MCO?

CME Group has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Moody's has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Which has stronger earnings & valuation, CME or MCO?

CME Group has higher earnings, but lower revenue than Moody's. CME Group is trading at a lower price-to-earnings ratio than Moody's, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CME Group	$6.28B	15.46	$3.53B	$9.94	27.13
Moody's	$7.23B	12.05	$2.06B	$11.58	41.78

Does the media refer more to CME or MCO?

In the previous week, CME Group had 1 more articles in the media than Moody's. MarketBeat recorded 27 mentions for CME Group and 26 mentions for Moody's. CME Group's average media sentiment score of 1.28 beat Moody's' score of 0.81 indicating that CME Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CME Group	21 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Moody's	14 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	3 Very Negative mention(s)	Positive

Do analysts rate CME or MCO?

CME Group currently has a consensus price target of $258.20, suggesting a potential downside of 4.25%. Moody's has a consensus price target of $519.40, suggesting a potential upside of 7.35%. Given Moody's' stronger consensus rating and higher probable upside, analysts plainly believe Moody's is more favorable than CME Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CME Group	3 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Moody's	1 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.53

Is CME or MCO a better dividend stock?

CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.9%. Moody's pays an annual dividend of $3.76 per share and has a dividend yield of 0.8%. CME Group pays out 50.3% of its earnings in the form of a dividend. Moody's pays out 32.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Moody's has increased its dividend for 16 consecutive years.

Do insiders & institutionals believe in CME or MCO?

87.8% of CME Group shares are owned by institutional investors. Comparatively, 92.1% of Moody's shares are owned by institutional investors. 0.3% of CME Group shares are owned by company insiders. Comparatively, 0.1% of Moody's shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is CME or MCO more profitable?

CME Group has a net margin of 57.52% compared to Moody's' net margin of 29.03%. Moody's' return on equity of 58.94% beat CME Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CME Group	57.52%	13.62%	2.81%
Moody's	29.03%	58.94%	14.87%

Does the MarketBeat Community favor CME or MCO?

CME Group received 118 more outperform votes than Moody's when rated by MarketBeat users. However, 59.11% of users gave Moody's an outperform vote while only 58.57% of users gave CME Group an outperform vote.

Company	Underperform	Outperform
CME Group	Outperform Votes 673 58.57%	Underperform Votes 476 41.43%
Moody's	Outperform Votes 555 59.11%	Underperform Votes 384 40.89%

Summary

Moody's beats CME Group on 13 of the 21 factors compared between the two stocks.